Rakovina Therapeutics Inc's stock has seen notable activity this week amidst fluctuating prices.
Rakovina Therapeutics Inc (RKV.V) has experienced a slight decline in its stock price this week, closing at C$0.25 on Thursday. This marks a 3.92% decrease in one day and a 2.00% drop over the week. Despite this recent downturn, the stock has appreciated significantly over the past month and year-to-date.
Advertisement
Rakovina Therapeutics Inc
RKV.V
RKV.V
Rakovina Therapeutics Inc
WealthAwesomeMarket cap
$6.23M
52W high
$0.36
52W low
$0.09
1W change
-2.00%
Beta
-0.10
Analyst Price Targets
Based on analyst covering RKV · as of Sep 17, 2026
Wall Street analysts forecast RKV stock price to rise 2.0% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.25
+2.0% Upside
Current Price
C$0.24
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on RKV's historical volatility
30-Day Vol
197.2%
Annualized
90-Day Vol
151.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.29
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.26 | C$0.13 – C$0.51 |
| 60 trading days | C$0.28 | C$0.11 – C$0.72 |
| 90 trading days | C$0.29 | C$0.09 – C$0.95 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should note the recent price fluctuations and volume spikes, which may indicate changing investor sentiment despite a lack of recent news. The technical indicators suggest a positive long-term trend, but caution is warranted given the current price action.
Recent Price Action Highlights Volatility
With a 1-day drop of 3.92% and a weekly drop of 2.00%, Rakovina's stock is experiencing volatility, even as it maintains a strong month-over-month performance.
Bull case
The stock has increased by 40% over the past month, showing strong investor interest and potential growth opportunities in Rakovina's therapeutic developments. Additionally, the stock's performance year-to-date reflects a substantial gain of 145%, suggesting a positive long-term outlook despite short-term volatility.
Bear case
The recent price declines may raise concerns about the sustainability of Rakovina's stock performance. The negative profit margin and high negative return on equity could signal underlying challenges that investors should consider. Furthermore, the lack of recent news may lead to uncertainty regarding the company's future prospects.
Recent Price Action
Advertisement
Rakovina Therapeutics Inc has faced a decline in its stock price this week, closing at C$0.25, which represents a 3.92% decrease in one day and a 2.00% decrease over the week. Despite these short-term setbacks, the stock has seen a remarkable increase of 40% over the past month and an impressive 145% year-to-date.
Volume Trends
The trading volume for Rakovina has spiked recently, with the latest volume reaching 6,951 shares, significantly higher than the 20-day average of 27,234 shares. This represents a volume that is 5.23 times the average, indicating heightened interest from investors, which could be a response to the stock's recent performance.
Technical Picture
From a technical standpoint, Rakovina Therapeutics shows a positive trend with its 50-day moving average at C$0.18, which is 35.3% above the current price, and a 200-day moving average at C$0.14, 77.6% above the price. The stock's 52-week range of C$0.09 to C$0.36 indicates it is currently at 59% of its range, while a beta of -0.10 suggests lower volatility relative to the market.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
